Emerging research shows there are ‘super-responders’ to GLP-1 drugs, and others who don’t respond at all.
Some GLP-1 users say they are experiencing fewer emotional highs and lows and decreased interest in hobbies and events that ...
GLP-1 receptor agonists may help improve outcomes among women with breast cancer and chronic cardiometabolic diseases, ...
GLP-1s currently make up a small portion of Medicaid prescriptions and spending before rebates are applied, but their share is growing. In 2023, GLP-1s accounted for 0.5% of prescriptions — compared ...
A common side effect of many GLP-1 drugs is hair loss. It's creating a formerly untapped but growing market for hair ...
New research may help ease concerns about the effect of drugs like Ozempic on muscles while also underscoring the importance ...